Caplin Point Laboratories Ltd. NSE: CAPLIPOINT | BSE: 524742

Mid-range Performer

Download real time

2107.70 -3.30 (-0.16%)

39.19% Gain from 52W Low

78,561

NSE+BSE Volume

High vol. this week

NSE 11 Aug, 2025 3:53 PM (IST)

Dividend

Caplin Point Laboratories Ltd. has an upcoming dividend of ₹3.00 per share due on 12 Sep 2025 See details

Caplin Point Laboratories Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Caplin Point Laboratories Ltd. on BSE

Load latest

Caplin Point Laboratories Ltd.

03 Apr 2025

2107.70

-0.16%

Company Update

Caplin Point Laboratories Ltd - 524742 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

Compliance Certificate under regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2025 is enclosed.

Caplin Point Laboratories Ltd.

02 Apr 2025

2107.70

-0.16%

Company Update

Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Acquisition

BSE India

Caplin Point Laboratories Limited informed that the Board of Directors of Caplin Point Far East Limited, Hong Kong, a material subsidiary of the Company had approved the investment in Neoethicals Chile SpA.

Caplin Point Laboratories Ltd.

29 Mar 2025

2107.70

-0.16%

Company Update

Caplin Point Laboratories Ltd - 524742 - Cautionary Letter From NSE And BSE On March 28, …

BSE India

Enclosing a copy of cautionary e-mail received from National Stock Exchange of India Limited and BSE Limited with respect to the intimation of Schedule of Investors/ Analyst''s Meet/ Call on August 30, 2024.

Caplin Point Laboratories Ltd.

25 Mar 2025

2107.70

-0.16%

SAST

Caplin Point Laboratories Ltd - 524742 - Closure of Trading Window

BSE India

Details regarding the closure of trading window is attached herewith.

Caplin Point Laboratories Ltd.

26 Feb 2025

2107.70

-0.16%

Company Update

CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press Release regarding receipt of USFDA Approval is attached herewith.

Caplin Point Laboratories Ltd.

14 Feb 2025

2107.70

-0.16%

Earnings Call

CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

The link for the transcript of the earnings call w.r.t financial performance of the company for quarter and nine months ended 31-12-2024 is enclosed.

Caplin Point Laboratories Ltd.

08 Feb 2025

2107.70

-0.16%

Company Update

CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Details relating to Newspaper Advertisement of Financial Results for the quarter and nine months ended December 31, 2024 is attached herewith

Caplin Point Laboratories Ltd.

07 Feb 2025

2107.70

-0.16%

Earnings Call

CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - …

BSE India

The web link for the audio recording of the Earnings call Q3 2024-25 held today i.e., Friday, February 02, 2025 at 17:00 hrs is enclosed

Caplin Point Laboratories Ltd.

07 Feb 2025

2107.70

-0.16%

Corp. Note

CAPLIN POINT LABORATORIES LTD. - 524742 - Integrated Filing (Financial)

BSE India

Integrated Filing (Financial) for Unaudited Financial Results for the quarter and nine months ended December 31, 2024 is enclosed

Caplin Point Laboratories Ltd.

07 Feb 2025

2107.70

-0.16%

Caplin Point Laboratories Results Earnings Call for Q3FY25

Conference Call with Caplin Point Laboratories Management and Analysts on Q3FY25 Performance and Outlook. Listen to the full earnings transcript.

Is Caplin Point Laboratories Ltd. worth buying?

482 Votes:

Buy 80.71%

Sell 12.24%

Hold 7.05%

RESEARCH REPORTS

Buy SEE REPORTS >

Buy SEE REPORTS >